Significant shareholders:
| Shareholder/Beneficial Owner | Shares | % ISC |
|---|---|---|
| Lombard Odier Investment Managers | 144,679,390 | 14.96 |
| Canaccord Genuity Wealth Management | 95,926,761 | 9.92 |
| T Rowe Price Global Investments | 79,524,807 | 8.22 |
| Hargreaves Lansdown, stockbrokers | 70,643,749 | 7.30 |
| Mr Richard Griffiths | 60,891,441 | 6.30 |
| Interactive Investor | 58,388,640 | 6.04 |
| Dr Andrew Nelson* | 38,835,514 | 4.01 |
| Janus Henderson Investors | 38,012,537 | 3.93 |
| Artisan Partners | 31,802,046 | 3.29 |
as at 31 January 2025
Quoted: AIM (London Stock Exchange)
Other Exchanges / Trading Platforms: The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue: 967,267,966 Ordinary shares.
Shares not in public hands: Insofar as the Company is aware, the percentage of securities that is not in public hands is 15.0%, these being held by directors, their families and significant shareholders.
Own shares held in treasury: The Company holds 4,115 Ordinary Shares in treasury.
Details on any restrictions on the transfer of securities: There are no restrictions on the transfer of securities.
Applicable code(s): The Company is subject to the UK City Code on Takeovers and Mergers. The Code is administered by The Panel and Takeovers in Mergers.
* Per the Company’s RNS announcement of 11 May 2020, 12,121,711 Ordinary Shares of Dr Nelson’s total beneficial interest are subject to a Sale and Repurchase Agreement with Equities First Holdings.